 "Drugs")
Among the coconut plantations and beaches of south India, a factory the size of 35 football fields is preparing to churn out billions of generic pills for HIV patients and flood the US market with the low-cost copycat medicines.
US patents on key components for some important HIV therapies are set to expire starting in December and Laurus Labs — the Hyderabad-based company which owns the facility — is gearing up to cash in.
Laurus is one of the world’s biggest suppliers of ingredients used in anti-retrovirals, thanks to novel chemistry that delivers cheaper production costs than anyone else. Now, its Chief
